FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10985611000001103: Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37493401000001112 Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
37493501000001111 Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Dasatinib monohydrate false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dasatinib false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Dasatinib monohydrate true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Dasatinib 50mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is pack of Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has active ingredient Dasatinib false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Dasatinib false Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sprycel 50mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start